MedTech Daily Briefing
2026-09-01
|
Section 1: MedTech Industry News
Boston Scientific discontinues angiographic catheters
MedTech Dive • August 31, 2026
|
Kardium receives $31M investment from Canada for manufacturing expansion
MedTech Dive • August 31, 2026
|
Edwards Lifesciences strategy VP will leave next year - MassDevice
MassDevice • August 31, 2026
|
Medtronic recalls reflux testing system after 184 serious injuries - MassDevice
MassDevice • September 01, 2026
|
Arthrex is expanding in Florida - MassDevice
MassDevice • August 31, 2026
|
Latest News on MassDevice - MassDevice
MassDevice • September 01, 2026
|
Stryker to acquire ZuriMed to boost shoulder offerings - MassDevice
MassDevice • August 31, 2026
|
Medtronic invests $780M in two companies amid Street-beating Q2 - MassDevice
MassDevice • September 01, 2026
|
GE HealthCare releases new Vivid technologies for cardiovascular imaging - MassDevice
MassDevice • August 31, 2026
|
Olympus launches Powerseal open extended jaw device - MassDevice
MassDevice • August 31, 2026
|
Boston Scientific halts sales of angiographic catheters amid ‘two serious injuries’
Fierce Biotech • September 01, 2026
|
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
Fierce Biotech • September 01, 2026
|
UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
Fierce Biotech • August 31, 2026
|
Natera teams with Angiex on cancer drug trial monitoring
Fierce Biotech • August 31, 2026
|
Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
Fierce Biotech • August 31, 2026
|
ESC26: AstraZeneca's heart failure drug shows promise in ph. 2 trial
Fierce Biotech • August 31, 2026
|
Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies
Fierce Biotech • August 31, 2026
|
|
Section 2: National News — MedTech Relevant
| No relevant national MedTech headlines today. |
|
Section 3: VC Press Releases
| No new VC press releases today. |
|
Section 4: Public Market Roundup — as of August 31, 2026
|
▲ Top Gainers
| NPCE |
Neuropace |
+1.67% |
| ALC |
Alcon |
+0.07% |
| MED.SW |
Medartis |
-3.15% |
|
|
▼ Top Losers
| MED.SW |
Medartis |
-3.15% |
| ALC |
Alcon |
+0.07% |
| NPCE |
Neuropace |
+1.67% |
|
📅 Upcoming Earnings (Next 7 Days)
| MDT |
Medtronic |
September 01, 2026 |
| MMED |
MiniMed |
September 01, 2026 |
|
|
MedTech Daily Briefing • Curated by automation
|
|